Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Indonesia earthquake and tsunami: Malteser International supports reconstruction of health facilities
10/05/2018. Malteser International has made emergency funds available to deliver essential relief materials to the surrounding communities.
Filippo Grandi takes helm as UN High Commissioner for Refugees
04/01/2017. Grandi, a UN official who has worked in refugee and political affairs in the Middle East, Africa, and Asia, succeeds António Guterres as UNHCR chief.
A record number of people will need help worldwide during 2020: UN Humanitarian Overview
12/04/2019. “In 2020, nearly 168 million people worldwide will need humanitarian assistance and protection,” he said. “That represents about one person in 45 on the planet. It is the highest figure in decades.”
